Roger Lassing
Corporate Officer/Principal en ICONOVO AB .
Perfil
Roger Lassing is currently the Vice President of Business Development at Iconovo AB.
Previously, he held positions as Vice President at Takeda Pharmaceutical Co., Ltd., Vice President & Global Brand Manager at AstraZeneca AB, and Senior Manager of Global Business Development at LEO Pharma AB.
Lassing received his undergraduate degree and MBA from the University of Lund.
Cargos activos de Roger Lassing
| Empresas | Cargo | Inicio |
|---|---|---|
| ICONOVO AB | Corporate Officer/Principal | 01/01/2019 |
Antiguos cargos conocidos de Roger Lassing.
| Empresas | Cargo | Fin |
|---|---|---|
| LEO Pharma AB | Corporate Officer/Principal | - |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | - |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | - |
Formación de Roger Lassing.
| University of Lund | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| ICONOVO AB | Health Technology |
| Empresas privadas | 2 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
| LEO Pharma AB |
- Bolsa de valores
- Insiders
- Roger Lassing
